Dr Matthias Zilbauer, of the University of Cambridge, has been awarded £100k for a project aiming to find a way to predict how a child’s condition is likely to progress if they are diagnosed with IBD – whether the child’s symptoms are likely to be mild and require minimal treatment, or more severe, needing more intensive treatment. Studies in adults suggest it might be possible to identify people who are at highest risk of having severe symptoms by analysing certain blood cells. Dr Zilbauer has been investigating whether this approach might also work for children and early results are promising. In this project, the team is finding out more about the potential benefits of the new test in children and simplifying the techniques used, so they are suitable for routine use. More information is available from the Action Medical Research website.